DR30206

DR30206 · Zhejiang Doer Biologics Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DR30206, covering 2025-07-03 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer [Phase 1, Phase 2]

See pricing